Volume 28, Issue 128 (May & June 2020)                   J Adv Med Biomed Res 2020, 28(128): 124-131 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kamaliaghdam M, Sadeghzadeh M, Jalilvand A, Eftekhari K, Rezaei Z. Antibiotic Sensitivity Patterns of Escherichia coli Isolated in Urine Samples of Patients Referred to Ayatollah Mousavi Hospital in Zanjan. J Adv Med Biomed Res 2020; 28 (128) :124-131
URL: http://journal.zums.ac.ir/article-1-5885-en.html
1- Dept. of Pediatrics, Ayatollah Moussavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2- Dept. of Pediatrics, Ayatollah Moussavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran , sadeghzadeh@zums.ac.ir
3- Dept. of Pathology, Ayatollah Moussavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
4- Dept. of Pediatrics, School of Medicine, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (143117 Views)

Background & Objective: Escherichia coli (E. coli) is considered to be the most common cause of urinary tract infections (UTIs) worldwide. Due to the recent rise in bacterial resistance to antibiotics and the appearance of multidrug-resistant E. coli, treatment options have been significantly limited, thus increasing the cost of treatment as well as morbidity and mortality rates, especially in developing countries. This study aimed to identify the antibiotic susceptibility patterns of E. coli for use in early empirical treatments and cultures of negative UTIs caused by previous antibiotic usage.
Materials & Methods: In the present study, 704 urine samples with a positive culture of E. coli were evaluated in terms of susceptibility to gentamycin, nitrofurantoin, ceftazidime, cefixime, meropenem, cefepime, azithromycin, ceftriaxone and ciprofloxacin using the Kirby-Bauer disc diffusion method. Data were collected based on age, sex, and hospitalization or ambulatory patient status. Data were analyzed using SPSS 22.0.
Results: E. coli showed the lowest resistance to nitrofurantoin (4.5%) and the highest resistance to cefixime (34.9). There was a statistically significant relationship between antibiotic resistance and age, gender, and hospitalization status
Conclusion: Because of the high resistance rate of E. coli to cefixime, precautions should be taken before using cefixime to treat UTIs.

Full-Text [PDF 402 kb]   (155245 Downloads) |   |   Full-Text (HTML)  (3014 Views)  

✅ Because of the high resistance rate of E. coli to cefixime, precautions should be taken before using cefixime to treat UTIs.


Type of Study: Original Article | Subject: Epidemiologic studies
Received: 2019/12/29 | Accepted: 2020/04/10 | Published: 2020/05/1

References
1. Matthews SJ, Lancaster JW. Urinary tract infections in the elderly population. Am J Geriatric Pharmacother. 2011; 9 (5): 286-309. [DOI:10.1016/j.amjopharm.2011.07.002]
2. Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control.2018;7:118. [DOI:10.1186/s13756-018-0411-4]
3. Odongo I, Ssemambo R, Kungu JM. Prevalence of Escherichia Coli and its antimicrobial susceptibility profiles among patients with UTI at Mulago Hospital, Kampala, Uganda. interdiscip Perspect Infect Dis. 2020;2020:8042540. doi: 10.1155/2020/8042540. eCollection 2020. [DOI:10.1155/2020/8042540]
4. Stefaniuk E, Suchocka U,Bosacka K, Hryniewicz W.Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland. Eur J Clin Microbiol Infect Dis. 2016;35(8):1363-9. doi: 10.1007/s10096-016-2673-1. [DOI:10.1007/s10096-016-2673-1]
5. Yekani M,Baghi HB,Sefidan FY,, Azargun R, Memar MY,Ghotaslou R. The rates of quinolone, trimethoprim/sulfamethoxazole and aminoglycoside resistance among Enterobacteriaceae isolated from urinary tract infections in Azerbaijan, Iran. GMS Hyg Infect Control. 2018;13:Doc07. doi: 10.3205/dgkh000313. eCollection 2018.
6. Conover MS, Hibbing ME, Hultgren S. Introduction to urinary tract infections. Metabolism of Human Diseases: Organ Physiology and Pathophysiology. 2014: 357. [DOI:10.1007/978-3-7091-0715-7_52]
7. Al Benwan K, Al Sweih N, Rotimi VO. Etiology and antibiotic susceptibility patterns of community- and hospital-acquired urinary tract infections in a general hospital in Kuwait. Med Princ Pract. 2010; 19 (6): 440-6. [DOI:10.1159/000320301]
8. Dibua UM, Onyemerela IS, Nweze EI. Frequency, urinalysis and susceptibility profile of pathogens causing urinary tract infections in Enugu State, southeast Nigeria. Magazine do Instituto de Medicina Tropical de São Paulo. 2014; 56 (1): 55-9. [DOI:10.1590/S0036-46652014000100008]
9. Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res. 2014;139(6):945-8.
10. Sudheendra Ramesh Kulkarni, Basavaraj V. Peerapur, Kumar Sai Sailesh. Isolation and antibiotic susceptibility pattern of Escherichia coli from urinary tract infections in a tertiary care hospital of north eastern Karnataka.J Nat Sci Biol Med. 2017; 8(2): 176-180. doi: 10.4103/0976-9668.210012 [DOI:10.4103/0976-9668.210012]
11. Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Brazil J Urol. 2007; 33 (1): 42-9. [DOI:10.1590/S1677-55382007000100007]
12. Mirsoleymani SR, Salimi M, Shareghi Brojeni M, Ranjbar M, Mehtarpoor M. Bacterial pathogens and antimicrobial resistance patterns in pediatric urinary tract infections: a four-year surveillance study (2009-2012). Int J Pediatr. 2014; Article ID 126142. https://doi.org/10.1155/2014/126142 [DOI:10.1155/2014/126142. .]
13. Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Natural Sci, Biol, and Med. 2016; 7 (1): 22. [DOI:10.4103/0976-9668.175020]
14. Gupta K, Hooton TM, Stamm WE. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. J Antimicrob Chemother. 2005; 56 (1): 243-6. [DOI:10.1093/jac/dki169]
15. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO • SENS study revisited. Int J Antimicrob Agents. 2012; 39 (1): 45-51. [DOI:10.1016/j.ijantimicag.2011.09.013]
16. Kulkarni SR, Peerapur BV, Sailesh KS. Isolation and antibiotic susceptibility pattern of Escherichia coli from urinary tract infections in a tertiary care hospital of North Eastern Karnataka. J Nat Sci Biol Med. 2017;8(2):176-180. doi: 10.4103/0976-9668.210012. [DOI:10.4103/0976-9668.210012]
17. Fasugba O, Mitchell BG, Mnatzagani an G, Das A, Collignon P, Gardner A . Five-year antimicrobial resistance patterns of urinary Escherichia Coli at an Australian Tertiary Hospital :Time series analyses of prevalence data.PLoS ONE. 2016; 11(10):e0164306.doi:10.1371/journal.pone.0164306. [DOI:10.1371/journal.pone.0164306]
18. Ferdosi-Shahandashti E, Javanian M, Moradian-Kouchaksaraei M, et al. Resistance patterns of Escherichia coli causing urinary tract infection. Caspian J Inter Med. 2015; 6 (3): 148.
19. Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary E coli among US outpatients from 2000 to 2010. Antimicrob Agent Chemother. 2012;56(4):2181-3. [DOI:10.1128/AAC.06060-11]
20. Alos JI , Serrano MG, Gomez Garces JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin J Microbiol Infect. 2005;11(3): 199-203. DOI: 10.1111 / j.1469-0691.2004.01057.x [DOI:10.1111/j.1469-0691.2004.01057.x]
21. Rosa R, Abbo LM, Raney K, Tookes HE 3rd, Supino M. Antimicrobial resistance in urinary tract infections at a large urban emergency department: Contributing factors to empirical treatment failure. Am J Emerg Med. 2017;35(3):397-401. doi: 10.1016/j.ajem.2016.11.021. Epub 2016 Nov 9 [DOI:10.1016/j.ajem.2016.11.021]
22. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and burden disease. Infect Dis Clin North Am. 2014; 28 (1): 1-13. [DOI:10.1016/j.idc.2013.09.003]
23. Spoorenberg V, Prins J, Stobberingh E, Hulscher M, Geerlings S. Adequacy of an evidence-based guideline treatment for complicated urinary tract infections in the Netherlands and the effectiveness of guideline adherence. Europ J Clin Microbiol & Infect Dis. 2013; 32 (12): 1545-56 [DOI:10.1007/s10096-013-1909-6]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb